Stock Comparison

RDY vs TAK

Dr. Reddy’s Laboratories Ltd ADR and Takeda Pharmaceutical Co Ltd ADR side by side — valuation, profitability, growth and risk.

RDY

Dr. Reddy’s Laboratories Ltd ADR

Healthcare

TAK

Takeda Pharmaceutical Co Ltd ADR

Healthcare

Valuation

Market Cap

$12.81B

$50.27B

P/E (TTM)

28.5

—

Forward P/E

28.5

10.3

Price/Sales

0.0

Price/Book

3.2

1.1

EV/EBITDA

14.1

16.9

Dividend Yield

0.54%

4.16%

Profitability

Net Margin

12.80%

-3.38%

Operating Margin

1.54%

11.10%

Return on Equity

11.80%

-2.12%

Return on Assets

5.74%

2.55%

Growth (YoY)

Revenue Growth

-11.60%

3.90%

Earnings Growth

-86.20%

330.20%

Price & Risk

Beta

0.3

0.1

52-Week High

$15.67

$18.90

52-Week Low

$12.19

$12.78

Analyst Target

$14.31

$20.60

Compare RDY and TAK your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.